Trial Profile
Eplerenone in the Management of Abdominal Aortic Aneurysms: A Proof-Of-Concept Randomised Controlled Trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary)
- Indications Abdominal aortic aneurysm
- Focus Proof of concept; Therapeutic Use
- 14 Jan 2016 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 29 Jan 2015 New trial record